Natalizumab in the treatment of patients with multiple sclerosis: first experience.

Mareckova, Helena

Natalizumab in the treatment of patients with multiple sclerosis: first experience. [electronic resource] - Annals of the New York Academy of Sciences Sep 2007 - 465-73 p. digital

Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0077-8923

10.1196/annals.1423.049 doi


Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
CD4-Positive T-Lymphocytes--drug effects
Female
Humans
Male
Middle Aged
Multiple Sclerosis--cerebrospinal fluid
Natalizumab
Receptors, CCR5--metabolism
Receptors, CXCR3--metabolism